Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
The poor survival rate (5-20%) of grafted embryonic dopamine (DA) neurons is one of the primary factors preventing cell replacement from becoming a viable treatment for Parkinson's disease. Previous studies have demonstrated that graft volume impacts grafted DA neuron survival, indicating that transplant parameters influence survival rates. However, the effects of mesencephalic cell concentration on grafted DA neuron survival have not been investigated. The current study compares the survival rates of DA neurons in grafts of varying concentrations. Mesencephalic cell suspensions derived from E14 Fisher 344 rat pups were concentrated to 25,000, 50,000, 100,000 and 200,000 cells/microl and transplanted into two 0.5 microl sites in the 6-OHDA-denervated rat striatum. Animals were sacrificed 10 days and 6 weeks post-transplantation for histochemical analysis of striatal grafts. The absolute number of DA neurons per graft increased proportionally to the total number of cells transplanted. However, our results show that the 200,000 cells/microl group exhibited significantly higher survival rates (5.48+/-0.83%) compared to the 25,000 cells/microl (2.81+/-0.39%) and 50,000 cells/microl (3.36+/-0.51%) groups (p=0.02 and 0.03, respectively). Soma size of grafted DA neurons in the 200,000 cells/microl group was significantly larger than that of the 25,000 cells/microl (p<0.0001) and 50,000 cells/microl groups (p=0.004). In conclusion, increasing the concentration of mesencephalic cells prior to transplantation, augments the survival and functionality of grafted DA neurons. These data have the potential to identify optimal transplantation parameters that can be applied to procedures utilizing stem cells, neural progenitors, and primary mesencephalic cells.
Terpstra
Brian T
BT
Department of Neurology, University of Cincinnati, PO Box 670525, Cincinnati, OH 45267-0525, United States. terp74@hotmail.com
Collier
Timothy J
TJ
Marchionini
Deanna M
DM
Levine
Nathan D
ND
Paumier
Katrina L
KL
Sortwell
Caryl E
CE
D000818:Animals; D016380:Brain Tissue Transplantation / Q000379:methods* / Q000592:standards; D002452:Cell Count; D018929:Cell Culture Techniques / Q000379:methods / Q000592:standards; D049109:Cell Proliferation; D002470:Cell Survival / Q000502:physiology; D002478:Cells, Cultured; D003342:Corpus Striatum / Q000166:cytology / Q000503:physiopathology / Q000601:surgery; D003714:Denervation; D004298:Dopamine / Q000378:metabolism*; D016332:Fetal Tissue Transplantation / Q000379:methods* / Q000592:standards; D007150:Immunohistochemistry; D008297:Male; D008636:Mesencephalon / Q000166:cytology / Q000196:embryology / Q000637:transplantation*; D009474:Neurons / Q000166:cytology / Q000378:metabolism / Q000637:transplantation*; D016627:Oxidopamine; D010300:Parkinson Disease / Q000628:therapy*; D051381:Rats; D011916:Rats, Inbred F344; D033581:Stem Cell Transplantation / Q000379:methods / Q000592:standards; D013378:Substantia Nigra / Q000166:cytology / Q000196:embryology / Q000637:transplantation; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D016627:Oxidopamine; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine
Ann N Y Acad Sci. 1987;495:473-96
3474955
Nature. 1992 Apr 2;356(6368):397-400
1557121
Exp Neurol. 2004 May;187(1):118-36
15081594
J Neurosci. 1995 Dec;15(12):8096-108
8613745
J Neural Transm (Vienna). 1998;105(2-3):253-63
9660103
Neuroscience. 1996 Dec;75(4):979-85
8938733
Ann Neurol. 2003 Sep;54(3):403-14
12953276
Annu Rev Neurosci. 1990;13:415-40
2183683
J Comp Neurol. 2003 Sep 15;464(2):172-9
12898610
Exp Brain Res. 1997 Aug;116(1):29-38
9305812
J Neurochem. 2004 Jun;89(5):1092-100
15147501
Exp Brain Res. 1995;106(2):275-82
8566192
Exp Neurol. 2000 Oct;165(2):268-77
10993687
Cell Mol Neurobiol. 2001 Aug;21(4):317-24
11775063
J Neurosci. 1999 Jul 1;19(13):5563-73
10377363
J Neurochem. 2002 Jan;80(1):168-77
11796755
Front Biosci. 2003 May 1;8:s522-32
12700087
Mov Disord. 2002;17 Suppl 3:S28-40
11948753
Cell Mol Neurobiol. 1998 Oct;18(5):487-96
9777249
Annu Rev Neurosci. 1999;22:123-44
10202534
Exp Neurol. 1997 Jun;145(2 Pt 1):511-23
9217087
Exp Neurol. 1993 Dec;124(2):368-71
8287932
Cell Transplant. 2004;13(3):273-82
15191165
Mol Biol Cell. 1993 Sep;4(9):953-61
8257797
Exp Neurol. 1996 Jan;137(1):105-18
8566202
Eur J Neurosci. 1998 Dec;10(12):3681-8
9875347
Neurology. 2004 Jan 13;62(1 Suppl 1):S47-55
14718680
Exp Brain Res. 1993;92(3):516-23
8095907
Neuroscience. 1994 Nov;63(1):57-72
7898661
J Comp Neurol. 2000 Jul 31;423(3):462-73
10870086
N Engl J Med. 2001 Mar 8;344(10):710-9
11236774
Anat Rec. 1946 Feb;94:239-47
21015608
Brain Res Dev Brain Res. 1993 Sep 17;75(1):65-73
7693370
Cell Transplant. 1993 Mar-Apr;2(2):151-62
7908247
Drugs Aging. 1999 Apr;14(4):261-87
10319241
Cell Adhes Commun. 1996 Sep;4(3):175-86
8969863